Generation of a Syngeneic Mouse Model to Study the Effects of Vascular Endothelial Growth Factor in Ovarian Carcinoma
- 1 December 2002
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 161 (6) , 2295-2309
Abstract
No abstract availableKeywords
Funding Information
- Fogarty International Center
- National Institute of Child Health and Human Development
- National Cancer Institute (CA 83638)
- National Institutes of Health (D43 TW00671)
This publication has 76 references indexed in Scilit:
- Detection of a decrease in green fluorescent protein fluorescence for the monitoring of cell death: An assay amenable to high-throughput screening technologiesCytometry, 2001
- Vascular Endothelial Growth Factor: Acting as an Autocrine Growth Factor for Human Gastric Adenocarcinoma Cell MGC803Biochemical and Biophysical Research Communications, 2001
- Tumor angiogenesis factors reduce leukocyte adhesion in vivoInternational Immunology, 2000
- The Hallmarks of CancerCell, 2000
- Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancerInternational Journal of Cancer, 1999
- Prognostic value of angiogenesis in gastro-intestinal tumoursEuropean Journal of Cancer, 1996
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996
- Molecular Mechanisms of Lymphocyte-Mediated Cytotoxicity and Their Role in Immunological Protection and Pathogenesis In VivoAnnual Review of Immunology, 1996
- Expression of Vascular Endothelial Growt Factor and Its Receptors fit and KDR in Ovarian CarcinomaJNCI: Journal of the National Cancer Institute, 1995
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochemical and Biophysical Research Communications, 1992